Tim Rollenske

Title: Tim Rollenske: Innovator in Monoclonal Antibody Development

Introduction

Tim Rollenske is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to the creation of a patent that addresses important aspects of immunology.

Latest Patents

Tim Rollenske holds a patent for "O3 specific antibodies." This patent describes a cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure. The antibody is characterized by specific CDR sequences or VH and VL sequences, which enhance its effectiveness in recognizing O3b, O3a, and O3 epitopes. He has 1 patent to his name.

Career Highlights

Throughout his career, Tim has worked with prominent organizations in the biotechnology sector. He has been associated with Arsanis Biosciences GmbH and the Max Planck Society for the Advancement of Science. His work in these institutions has allowed him to further his research and contribute to advancements in antibody technology.

Collaborations

Tim Rollenske has collaborated with several talented individuals in his field. Notable coworkers include Valeria Szijárto and Gábor Nagy, who have contributed to his research endeavors.

Conclusion

Tim Rollenske is a distinguished inventor whose work in monoclonal antibodies has made a significant impact in biotechnology. His patent for O3 specific antibodies showcases his innovative approach to addressing complex immunological challenges.